Physician profile
Douglas Geiger
NPI 1891750188
$20,812.04
in general payments reported to CMS, 2019-2025
14 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $7,715 · 2021: $1,460 · 2022: $8,178 · 2023: $2,689 · 2024: $439 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,432 · Food and Beverage: $836 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,431.86 |
| Food and Beverage | $836.32 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $6,893.22 | 2019-2025 | Velys, Vivigen Mis Delivery System |
| Nuvasive, INC. | $6,291.72 | 2019-2020 | |
| Globus Medical, INC. | $2,777.37 | 2020-2022 | |
| Medical Device Business Services, INC. | $2,733.72 | 2021-2023 | |
| Stryker Corporation | $1,201.84 | 2020-2021 | |
| Medtronic, INC. | $431.69 | 2021-2024 | Unid_pass, Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Depuy Synthes Products, INC. | $149.47 | 2021 | |
| Centinel Spine, LLC | $133.00 | 2021 | |
| Si-Bone, INC. | $94.85 | 2019-2025 | |
| Djo, LLC | $27.30 | 2022 | |
| Medtronic USA, INC. | $26.98 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Titan Spine, LLC | $16.20 | 2019 | |
| Merck Sharp & Dohme LLC | $14.68 | 2025 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Geiger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.